From: Understanding disease mechanisms with models of signaling pathway activities
 | Circuits | SEA |  |  | ||||
---|---|---|---|---|---|---|---|---|
PATHWAY | Total | Case | Control | UP vs DOWN | UP vs ALL | DOWN vs ALL | GSEA | SPIA |
PPAR SIGNALING PATHWAY | 106 | 3 | 19 | DOWN | ALL | ALL | DOWN* | INH* |
ERBB SIGNALING PATHWAY | 139 | 11 | 2 | UP | UP | DOWN | DOWN* | INH |
CALCIUM SIGNALING PATHWAY | 20 | 2 | 2 | DOWN | UP | DOWN | UP* | ACT |
NEUROACTIVE LIGAND-RECEPTOR INTERACTION | 7 | 0 | 0 | UP | UP | ALL | UP* | ACT |
APOPTOSIS | 28 | 0 | 0 | DOWN | ALL | DOWN | DOWN* | INH |
WNT SIGNALING PATHWAY | 37 | 6 | 6 | UP | UP | DOWN | DOWN* | INH |
NOTCH SIGNALING PATHWAY | 14 | 0 | 0 | DOWN | ALL | ALL | DOWN | INH |
VEGF SIGNALING PATHWAY | 10 | 2 | 0 | DOWN | ALL | ALL | DOWN | INH |
CELL ADHESION MOLECULES | 43 | 6 | 3 | UP | UP | ALL | UP* | - 1 |
GAP JUNCTION | 17 | 4 | 0 | UP | UP | ALL | UP* | ACT |
ANTIGEN PROCESSING AND PRESENTATION | 6 | 0 | 0 | DOWN | ALL | DOWN | UP | ACT |
TOLL-LIKE RECEPTOR SIGNALING PATHWAY | 103 | 0 | 0 | UP | UP | DOWN | UP* | INH |
JAK-STAT SIGNALING PATHWAY | 7 | 7 | 0 | DOWN | ALL | DOWN | UP* | INH |
B CELL RECEPTOR SIGNALING PATHWAY | 10 | 0 | 0 | UP | UP | ALL | UP* | INH |
Fc EPSILON RI SIGNALING PATHWAY | 7 | 0 | 0 | UP | ALL | ALL | DOWN* | INH |
INSULIN SIGNALING PATHWAY | 54 | 1 | 0 | DOWN | UP | ALL | DOWN* | INH |
GnRH SIGNALING PATHWAY | 9 | 0 | 0 | UP | UP | ALL | DOWN* | ACT |
MELANOGENESIS | 8 | 1 | 0 | UP | ALL | ALL | UP | ACT |
ADIPOCYTOKINE SIGNALING PATHWAY | 31 | 0 | 2 | DOWN | ALL | ALL | UP | INH |